Tradestie Institutional Equity Comparison Engine

ITRM vs SPRO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SPRO Overall Edge

SPRO Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Spero Therapeutics, Inc. Common Stock (SPRO) driven by superior Growth & Margin, Momentum & Technical while ITRM counters with relative strength in Options & Structure. Fundamentally, ITRM trades at N/M Forward P/E with -1982.3% operating margin (-100.0% YoY revenue) versus SPRO at N/M Forward P/E and 16.9% operating margin (-95.6% YoY). In options structure, ITRM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SPRO sits in BREAKDOWN (46th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ITRM N/M vs SPRO N/M Fwd P/E
Growth & Margin Winner SPRO
Op Margin -1982.3% vs 16.9% ยท YoY -100.0% vs -95.6%
Momentum & Technical Winner SPRO
1Y -97.6% vs -68.8% ยท 52W Pos 0% vs 0%
Options & Structure Winner ITRM
UNCLASSIFIED (N/A IV) vs BREAKDOWN (46th %ile IV)
ITRM NASDAQ
Iterum Therapeutics plc Ordinary Share
Pharmaceutical Preparations
$0.03
-57.39% 1D
Market Cap $3.8M
1M Return -89.38%
1Y Return -97.62%
Forward P/E N/M
Unified AI Score
50.5 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 50.0 Mom 75.0
SPRO NASDAQ
Spero Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$0.74
-10.2% 1D
Market Cap $46.2M
1M Return -34.34%
1Y Return -68.82%
Forward P/E N/M
Unified AI Score
44.8 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 66.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ITRM -97.62% SPRO -68.82% Spread: +90.53 pp (SPRO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ITRM TTM Op. Margin: -1982.3% SPRO TTM Op. Margin: 16.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ITRM vs SPRO. Trailing 12-month operating profitability (ITRM -1982.3% vs SPRO 16.9%) and valuation multiples (ITRM N/M vs SPRO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ITRM (2) vs SPRO (5)
Institutional Metric ITRM SPRO Criterion Row Winner
Market Capitalization Scale $3.8M $46.2M Larger Scale SPRO
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% -95.6% Higher Growth SPRO
Operating Margin (TTM) Profitability -1982.3% 16.9% Higher Margin SPRO
Net Profit Margin Profitability 0.0% -71.0% Higher Margin ITRM
Return on Equity (ROE) Capital Efficiency -555.7% -216.4% Higher ROE SPRO
52-Week Range Position Momentum 0% ($0โ€“$1) 0% ($1โ€“$3) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.61ฮฒ ยท 508% Vol 1.84ฮฒ ยท 60% Vol Lower Realized Risk SPRO
Unified Institutional Score Composite Signal 50.5 / 100 (HOLD) 44.8 / 100 (HOLD) Higher Composite ITRM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ITRM vs SPRO Buy Guide
ITRM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ITRM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SPRO BREAKDOWN
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 46th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SPRO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ITRM nor SPRO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.